ClinicalThought

Share

Program Content

Activities

  • HCC Second Line
    Selecting Second-line Treatment After Atezolizumab Plus Bevacizumab for Patients With Advanced HCC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 01, 2020

    Expires: September 30, 2021

  • HCC: ASCO GI 2021 Updates
    Key Updates in HCC Treatment From ASCO GI 2021
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 11, 2021

    Expires: February 10, 2022

Faculty

cover img faculity

Lipika Goyal, MD, MPhil

Associate Professor of Medicine
Director of Gastrointestinal Medical Oncology
Stanford Cancer Center
Palo Alto, California

cover img faculity

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

cover img faculity

Mark Yarchoan, MD

Associate Professor of Medical Oncology
Division of GI Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

Provided by

ProCE Banner

Supporters

AstraZeneca

Genentech, a member of the Roche Group

Lilly